Teneobio, Inc. Employee Directory

BiotechnologyCalifornia, United States51-200 Employees

Teneobio, Inc. is a biotechnology company focused on discovering and developing a new class of therapeutics built from human heavy chain antibodies, known as UniAbs. Their approach aims to deliver highly specific antibodies with strong developability, enabling single-domain constructs that can be combined with other components to create multi-specific or longer-lasting therapies. The company targets cancer, autoimmune disorders, and infectious diseases, with several pre-clinical and clinical programs including treatments for multiple myeloma, prostate cancer, and immune-related conditions. Its discovery engine leverages a heavy chain–only transgenic rat and a sequence-based pipeline to identify diverse UniAb leads that cover broad epitopes on target antigens. In addition to bispecific formats that redirect immune responses, Teneobio has developed UniDabs as versatile building blocks for potential therapeutic constructs, including immune-oncology and checkpoint inhibition strategies.

Sign up for free to view info

Company overview Email format